Literature DB >> 6193091

Retrostatin, a new specific enzyme inhibitor against avian myeloblastosis virus reverse transcriptase.

M Nishio, A Kuroda, M Suzuki, K Ishimaru, S Nakamura, R Nomi.   

Abstract

A novel enzyme inhibitor against RNA-directed DNA polymerase of avian myeloblastosis virus was produced by an isolate of a new streptomycete for which the name Streptomyces retrostaticus is proposed. This enzyme inhibitor, which was named retrostatin, did not inhibit DNA-directed DNA polymerase of Escherichia coli and DNA-directed RNA polymerase of Ehrlich ascites tumor cells. Retrostatin was produced by the microorganism together with streptonigrin. These two substances were extracted from the culture broth with ethyl acetate at acidic pH. Retrostatin is an acidic pH indicator and the free acid was recovered as a red powder. Retrostatin had weak antibiotic activities against Gram-positive bacteria and yeasts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193091     DOI: 10.7164/antibiotics.36.761

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  1 in total

1.  Mechanism of tumor cell killing by HO-221, a novel antitumor compound.

Authors:  T Nakajima; T Okamoto; H Masuda; M Watanabe; K Yokoyama; N Yamada; S Tsukagoshi; T Taguchi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.